Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature-Reference-Cited by-同舟云学术

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature

Published:2019-11-21 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Safa Houssein^ORCID,Johnson Daniel H,Trinh Van Anh,Rodgers Theresa E,Lin Heather,Suarez-Almazor Maria E,Fa’ak Faisal,Saberian Chantal,Yee Cassian,Davies Michael A,Tummala Sudhakar,Woodman Karin,Abdel-Wahab Noha,Diab Adi^ORCID

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0774-y.pdf

Reference50 articles.

1. Opdivo-nivolumab [package insert]. Princeton NBMS, 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125554s073lbl.pdf .

2. YERVOY-ipilimumab [package insert]. Princeton NBS, 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125377s102lbl.pdf .

3. KEYTRUDA- Pembrolizumab [package insert]. County Cork IM, 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125514s053lbl.pdf .

4. Eggermont AM. Adjuvant ipilimumab in stage III melanoma: new landscape, new questions. Eur J Cancer. 2016;69:39–42.

5. Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, et al. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Lancet Oncol. 2015;16(5):522–30.

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitor-related myasthenia gravis, myositis and myocarditis: a triad but not at the same time?;QJM: An International Journal of Medicine;2024-01-16

2. A Case of Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab: A Case Report;Internal Medicine;2024

3. Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events;Frontiers in Immunology;2023-12-12

4. Myasthenia Gravis Associated With Pembrolizumab for Relapsed Lung Cancer After Thymoma Resection;Cureus;2023-12-01

5. Pembrolizumab-induced Myopathy with Anti-striated Muscle Antibodies Successfully Treated by Plasma Exchange;Internal Medicine;2023-12-01